Retinal changes: a mortality risk in non-diabetics

Article

A study published in the September issue of the American Journal of Epidemiology, suggests that retinal changes have possible prognostic implications regarding the survival of persons with diabetes.

A study published in the September issue of the American Journal of Epidemiology, suggests that retinal changes have possible prognostic implications regarding the survival of persons with diabetes.

Despite retinopathy being fairly common among non-diabetics, its prognostic implications are not fully understood. Ronald Klein and colleagues from the University of Wisconsin, USA and the Federal University of Sao Paulo, Brazil hypothesized that retinal alterations are associated with increased mortality. In order to investigate this, they evaluated survival rates among 4,292 non-diabetic participants (age range, 43-84 years) of the Beaver Dam Eye Study.

Retinal photographs were used to classify retinopathy into four groups: no retinopathy, retinal haemorrhage only, retinal micro-aneurysm or moderate or worse retinopathy. Survival was analyzed over a 14-year follow-up period in five-year intervals.

The baseline prevalence of retinopathy was 7.6%. After the 14-year follow-up period it was discovered that moderate retinopathy, at baseline, increased the risk of all-cause mortality by 24% and ischaemic heart disease by more than three-fold.

Based on these results, the researchers believe that retinal changes do have possible prognostic implications regarding the survival of persons without diabetes.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.